statistiche ricercatore

ACCOLLA, ROBERTO

Distribuzione geografica

Continente	#
NA - Nord America	21.340
EU - Europa	15.602
AS - Asia	7.509
SA - Sud America	897
AF - Africa	81
OC - Oceania	23
Continente sconosciuto - Info sul continente non disponibili	13
Totale	45.465

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	21.036
IT - Italia	7.653
UA - Ucraina	2.750
SG - Singapore	2.490
TR - Turchia	1.416
DE - Germania	1.265
CN - Cina	1.195
VN - Vietnam	1.086
SE - Svezia	1.064
HK - Hong Kong	963
BR - Brasile	796
FI - Finlandia	670
IE - Irlanda	663
RU - Federazione Russa	483
GB - Regno Unito	480
FR - Francia	266
CA - Canada	194
IN - India	104
MX - Messico	93
PL - Polonia	71
JP - Giappone	69
BE - Belgio	47
ES - Italia	43
AR - Argentina	42
ZA - Sudafrica	38
NL - Olanda	37
BD - Bangladesh	33
IQ - Iraq	26
LT - Lituania	23
PK - Pakistan	23
AT - Austria	18
AU - Australia	18
CZ - Repubblica Ceca	14
EC - Ecuador	14
KR - Corea	14
CH - Svizzera	12
EU - Europa	12
MA - Marocco	12
AE - Emirati Arabi Uniti	11
PY - Paraguay	11
SA - Arabia Saudita	10
UZ - Uzbekistan	9
VE - Venezuela	9
CO - Colombia	8
ID - Indonesia	8
IR - Iran	8
CL - Cile	6
KE - Kenya	6
BY - Bielorussia	5
DZ - Algeria	5
EG - Egitto	5
LB - Libano	5
NZ - Nuova Zelanda	5
TN - Tunisia	5
JM - Giamaica	4
MY - Malesia	4
PE - Perù	4
RO - Romania	4
RS - Serbia	4
TT - Trinidad e Tobago	4
TW - Taiwan	4
BH - Bahrain	3
DK - Danimarca	3
GE - Georgia	3
GR - Grecia	3
GY - Guiana	3
HR - Croazia	3
JO - Giordania	3
KZ - Kazakistan	3
LU - Lussemburgo	3
PS - Palestinian Territory	3
AL - Albania	2
BG - Bulgaria	2
BN - Brunei Darussalam	2
BO - Bolivia	2
CI - Costa d'Avorio	2
DO - Repubblica Dominicana	2
ET - Etiopia	2
HU - Ungheria	2
IL - Israele	2
LV - Lettonia	2
MT - Malta	2
NG - Nigeria	2
NP - Nepal	2
QA - Qatar	2
UY - Uruguay	2
AM - Armenia	1
AO - Angola	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
CR - Costa Rica	1
GA - Gabon	1
GH - Ghana	1
GT - Guatemala	1
HN - Honduras	1
KH - Cambogia	1
KW - Kuwait	1
LI - Liechtenstein	1
LK - Sri Lanka	1
Totale	45.451

Salva come PNG Salva come JPEG

Città	#
Milan	5.721
Fairfield	2.139
Jacksonville	2.111
Woodbridge	1.748
Chandler	1.580
Ashburn	1.471
Singapore	1.333
Ann Arbor	1.181
Houston	1.160
Hong Kong	959
Seattle	910
Wilmington	910
Dallas	797
Izmir	764
Princeton	716
Dearborn	698
Cambridge	694
Dublin	660
Nyköping	541
Beijing	522
Dong Ket	430
Boardman	426
Rome	411
San Mateo	242
Como	238
The Dalles	225
New York	216
Los Angeles	175
San Diego	165
Chicago	157
Ogden	140
Toronto	115
São Paulo	97
Munich	95
Santa Clara	93
Düsseldorf	83
London	80
Verona	71
Tokyo	67
Hefei	62
Helsinki	60
Warsaw	58
Mexico City	54
Ho Chi Minh City	53
Nanjing	48
Kunming	46
Brussels	45
Norwalk	42
Brooklyn	39
Orem	39
Buffalo	38
Hanoi	38
Turku	36
Guangzhou	35
Jinan	35
Boston	32
Frankfurt am Main	32
Pune	32
Council Bluffs	31
Stockholm	30
Washington	30
Denver	29
Kocaeli	29
Montreal	28
Phoenix	28
Johannesburg	26
Manchester	25
Chennai	22
Fuzhou	22
San Francisco	22
Poplar	21
Amsterdam	20
Redwood City	20
Belo Horizonte	18
Falls Church	18
St Petersburg	18
Atlanta	17
Rio de Janeiro	17
Columbus	16
Nuremberg	16
Nanchang	15
Shanghai	15
Sydney	15
Auburn Hills	14
Berlin	14
Edinburgh	14
Kilburn	14
Querétaro	14
Wuhan	14
Curitiba	13
Hangzhou	13
Vienna	13
Fortaleza	12
Gallarate	12
Hebei	12
Shenyang	12
Brasília	11
Changsha	11
Goiânia	11
San Jose	11
Totale	31.728

Salva come PNG Salva come JPEG

Nome	#
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response	245
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	238
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	226
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	225
Unsung hero Robert C. Gallo	220
Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines	218
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line	215
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens	214
Antibody-mediated activation of a deletion-mutant b-galactosidase defective in the a-region	214
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	211
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	206
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	202
Demonstration at the single cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets	200
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques	200
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	199
An enhancer factor defect in a mutant Burkitt lymphoma cell line	197
Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma	196
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.	195
Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb	195
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	194
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	193
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches	193
Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy	192
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.	192
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	192
Functional significance of polymorphism among MHC class II gene promoters	192
Host defense mechanisms against pathogens	189
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients	189
Detection of human chromosomes in somatic cell hybrids by PCR analysis	189
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	188
Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen "CEA".	187
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	185
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	185
Allogeneic mixed lymphocyte reactions in humans : Pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation	183
The MHC class II transactivator: prey and hunter in infectious diseases	182
Human adipose-derived stem cells promote vascularization of collagen-based scaffolds transplanted into nude mice	181
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	180
Biochemical aspects of human Ia molecules	180
Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human	180
APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis	180
H2-RESTRICTED RECOGNITION OF CLONED HLA CLASS-I GENE-PRODUCTS EXPRESSED IN MOUSE CELLS	180
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation	179
Transcriptional regulation of MHC class II genes	177
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	176
Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids	176
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	175
Monoclonal antibodies against carcinoembryonic antigen (CEA) used in solid-phase enzyme immunoassay	174
Analisi dell’espressione genica in cellule epiteliali umane trattate con la proteina Tat di HIV	174
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	174
Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family	173
Autoimmunità e Malattie Autoimmuni	173
Reducing the global burden of HTLV-1 infection: An agenda for research and action	173
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.	172
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	172
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	172
The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets	171
Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody	170
New strategies of mammary cancer vaccination	170
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells	170
Somatic cell hybrids producing antibodies specific to human fibronectin.	169
In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator	169
Analysis of the antigen specific T cell repertoire in HIV infection	169
IL-2 mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.	168
Distinct forms of both a and b subunits are present in the human Ia molecular pool	168
Subsets of human Ia-like molecules defined by monoclonal antibodies	168
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	168
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.	167
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory	167
SUSCEPTIBILITY OF HUMAN-MOUSE T-CELL HYBRIDS TO HIV-PRODUCTIVE INFECTION	167
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	165
Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.	162
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.	162
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	162
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses	162
ras-Family gene mutations in neoplasia of the ampulla of Vater	161
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen	161
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	160
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	160
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine	160
Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.	159
Idiotype-specific neonatal suppression of phosphorylcholine-responsive B cells.	158
Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.	158
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	157
Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class-II antigens	157
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	156
Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment	155
Tumor Immunology meets Immunology: Modified cancer cells as professional APC for priming naÃ¯ve tumor-specific CD4+ T cells	155
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	154
Isolation of cDNA clones encoding HLA-DR a chains	153
Interspecies somatic T cell hybrids as biological tools for studying gene expression during T cell development	153
Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.	152
Insight into the molecular mechanism of CIITA-mediated inhibition of HIV-1 and HTLV transactivators	152
A dual defensive role of CIITA against retroviral infections	152
MHC: Orchestrating the immune response	152
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	152
Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes	151
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	151
Screening transplant donors for HTLV-1 and -2	151
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	150
Treg function as a marker to define the susceptibility to T1DM clinical onset in a healthy subject with antibodies positivity?	150
Totale	17.766

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	176.177
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	176.177

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3.558	0	0	0	0	0	517	165	493	806	232	462	883
2021/2022	3.229	392	414	271	231	114	95	124	219	150	468	278	473
2022/2023	4.358	470	150	270	468	343	947	6	640	633	135	167	129
2023/2024	8.694	1.434	1.405	1.535	1.536	1.645	542	64	110	272	44	18	89
2024/2025	4.898	53	74	928	149	222	235	218	321	563	300	402	1.433
2025/2026	4.987	763	658	542	1.610	1.087	327	0	0	0	0	0	0
Totale													45.676